152 related articles for article (PubMed ID: 31677109)
1. Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy.
Coon C; Berger N; Eastwood D; Tsai S; Christians K; Mogal H; Clarke C; Gamblin TC
Ann Surg Oncol; 2020 Apr; 27(4):1156-1163. PubMed ID: 31677109
[TBL] [Abstract][Full Text] [Related]
2. Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base.
Liu C; Rein L; Clarke C; Mogal H; Tsai S; Christians KK; Gamblin TC
J Surg Oncol; 2020 Aug; 122(2):176-182. PubMed ID: 32383268
[TBL] [Abstract][Full Text] [Related]
3. Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma.
Lee GC; Gamblin TC; Fong ZV; Ferrone CR; Goyal L; Lillemoe KD; Blaszkowsky LS; Tanabe KK; Qadan M
Ann Surg Oncol; 2019 Nov; 26(12):4091-4099. PubMed ID: 31368018
[TBL] [Abstract][Full Text] [Related]
4. Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival.
Wu L; Tsilimigras DI; Paredes AZ; Mehta R; Hyer JM; Merath K; Sahara K; Bagante F; Beal EW; Shen F; Pawlik TM
World J Surg; 2019 Jul; 43(7):1777-1787. PubMed ID: 30820734
[TBL] [Abstract][Full Text] [Related]
5. Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database.
Salehi O; Kazakova V; Vega EA; Kutlu OC; Alarcon SV; Freeman R; Kozyreva O; Conrad C
Surg Endosc; 2022 Jul; 36(7):5382-5391. PubMed ID: 34750709
[TBL] [Abstract][Full Text] [Related]
6. Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study.
Gou XX; Shi HY; Li C; Chen ZL; Ouyang W; Sun LY; Diao YK; Wang MD; Yao LQ; Gu LH; Pawlik TM; Lau WY; Shen F; Xue J; Yang T
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):238-249. PubMed ID: 35643251
[TBL] [Abstract][Full Text] [Related]
7. Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.
Tsilimigras DI; Sahara K; Moris D; Hyer JM; Paredes AZ; Bagante F; Merath K; Farooq AS; Ratti F; Marques HP; Soubrane O; Azoulay D; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
J Gastrointest Surg; 2020 Jul; 24(7):1552-1560. PubMed ID: 31243714
[TBL] [Abstract][Full Text] [Related]
8. Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics.
Bergquist JR; Groeschl RT; Ivanics T; Shubert CR; Habermann EB; Kendrick ML; Farnell MB; Nagorney DM; Truty MJ; Smoot RL
HPB (Oxford); 2016 Nov; 18(11):886-892. PubMed ID: 27546172
[TBL] [Abstract][Full Text] [Related]
9. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
Kamarajah SK; Bednar F; Cho CS; Nathan H
Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
[TBL] [Abstract][Full Text] [Related]
10. Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function.
Benjamin AJ; Baker TB; Talamonti MS; Bodzin AS; Schneider AB; Winschester DJ; Roggin KK; Bentrem DJ; Suss NR; Baker MS
Surgery; 2018 Mar; 163(3):582-586. PubMed ID: 29370929
[TBL] [Abstract][Full Text] [Related]
11. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis.
Ma KW; Chok KSH; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM
Hepatol Int; 2018 Mar; 12(2):167-173. PubMed ID: 29450868
[TBL] [Abstract][Full Text] [Related]
12. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
[No Abstract] [Full Text] [Related]
13. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.
Groeschl RT; Turaga KK; Gamblin TC
J Surg Oncol; 2013 May; 107(6):608-12. PubMed ID: 23386397
[TBL] [Abstract][Full Text] [Related]
14. Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.
Chapman BC; Paniccia A; Hosokawa PW; Henderson WG; Overbey DM; Messersmith W; McCarter MD; Gleisner A; Edil BH; Schulick RD; Gajdos C
J Am Coll Surg; 2017 Mar; 224(3):362-372. PubMed ID: 27923615
[TBL] [Abstract][Full Text] [Related]
15. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
[TBL] [Abstract][Full Text] [Related]
16. Dissemination of Minimally Invasive Liver Resection for Primary Malignancy: Reevaluating Effectiveness.
Varley PR; Tohme ST; Chidi AP; Goswami J; van der Windt D; Geller DA; Tsung A
Ann Surg Oncol; 2018 Mar; 25(3):808-817. PubMed ID: 29302818
[TBL] [Abstract][Full Text] [Related]
17. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
[TBL] [Abstract][Full Text] [Related]
18. Anatomical Resection But Not Surgical Margin Width Influence Survival Following Resection for HCC, A Propensity Score Analysis.
Lee JW; Lee YJ; Park KM; Hwang DW; Lee JH; Song KB
World J Surg; 2016 Jun; 40(6):1429-39. PubMed ID: 26817652
[TBL] [Abstract][Full Text] [Related]
19. Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients.
Donadon M; Terrone A; Procopio F; Cimino M; Palmisano A; Viganò L; Del Fabbro D; Di Tommaso L; Torzilli G
Surgery; 2019 May; 165(5):897-904. PubMed ID: 30691871
[TBL] [Abstract][Full Text] [Related]
20. Impact of marginal resection for hepatocellular carcinoma.
Kobayashi N; Aramaki O; Midorikawa Y; Higaki T; Nakayama H; Moriguchi M; Takayama T
Surg Today; 2020 Nov; 50(11):1471-1479. PubMed ID: 32472316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
